Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(17 sites)

United States

Research Site, Anniston, Alabama

Research Site, Lake Forest, California

Research Site, Lomita, California

Research Site, Hazelwood, Missouri

Research Site, Columbus, Ohio

Research Site, Moncks Corner, South Carolina

Research Site, Chattanooga, Tennessee

Research Site, Knoxville, Tennessee

Research Site, Austin, Texas

Research Site, DeSoto, Texas

Research Site, Houston, Texas

Research Site, Mesquite, Texas

Research Site, San Antonio, Texas

Research Site, Tomball, Texas